The Biggest Problems in Pharma Logistics Don't Always Need Bigger Solutions
One thing has become increasingly clear to me in 2026: some of the biggest problems in pharmaceutical logistics persist not because we haven't invested enough in solving them, but because we've made the solutions too complicated.
I've spent a lot of this year in warehouses, pharmacies, virtual calls, and conference rooms with the people who move medicine. Three problems came up again and again. These aren't new challenges. The industry has invested significant time, money, and technology trying to solve them. But I think some of our assumptions about what makes a solution effective deserve another look.
Problem 1: Too Many Reships and Failed Deliveries
Most companies have attacked this problem on two fronts: more visibility and faster delivery. Yet the problem remains. Here's why.
Visibility shows you a problem. It doesn't solve it. A dashboard that tells you a shipment went out of range on a hot tarmac is information. It's still a reship. Faster delivery has a similar limitation. Shipments that were already going to arrive successfully get there sooner, but speed alone doesn't eliminate the disruptions that cause deliveries to fail. Sometimes, it just makes the same failure more expensive.
So what actually changes the outcome? Two things working together. First, a shipping solution that protects the product long enough to absorb the disruptions that inevitably happen. That's reliability. Second, active delivery management that acts on shipments still at risk. When a delivery attempt fails because a receiving office is temporarily closed, visibility should trigger action. Contact the recipient, coordinate with the carrier, and get the shipment back on track before it becomes a reship.
The goal isn't simply to know more about what's happening. It's to change what happens next and proactively change to avoid the problem happening next time.
Problem 2: Operational Complexity
When we see a complex challenge, we naturally assume it needs a complex solution. And that's exactly what the industry built. Destination pack-outs. Seasonal pack-outs. Different boxes for different products. Customizations based on product value.
Each variation was designed to solve a specific problem. But collectively, they create another one: more inventory, more training, more opportunities for error, and more dependencies that can bring operations to a halt. If one component arrives a day late, shipments stall.
In my experience, the more complex the challenge, the simpler the solution must be. One pack-out that performs in every season, to every destination, with fewer components on the shelf, is easier to teach, easier to stock, and much harder to get wrong.
Problem 3: Maxed-Out Physical Space
Growth is constrained by two things: space and time. And both are directly connected to the operational complexity we've built into pharmaceutical logistics.
Think about all those destination pack-outs, seasonal pack-outs, and extra components. They all have to live somewhere. Every pallet of packaging takes up space that could otherwise support the movement and storage of medicine. But physical space is only part of the equation. There are also only so many hours in a shipping week, and traditional packaging often dictates when a shipment can safely leave a facility.
We’ve been able to unlock 20% more shipping capacity without changing our customers facility by using packaging qualified to protect medicine through a weekend delivery. We extended the shipping week and created more capacity from the same footprint.
When you combine that flexibility with simpler pack-outs and reduced inventory requirements, the opportunity becomes even greater. You can move more medicine through the same operation without building, leasing, or hiring your way out of the problem.
Connected Problems. Simpler Solutions.
These three problems are connected, and so are the answers. Reliability makes simplicity possible, because one pack-out only works if it performs in any season. Simplicity creates capacity, because fewer components and fewer decisions make operations easier to scale. And visibility only delivers its full value when it leads to action.
That's what we've been building at AeroSafe Global. Reliability, Actionable Visibility, and Operational Excellence aren't three independent solutions. They're a system where each makes the others more effective. Better reliability reduces the need for operational complexity. Simpler operations create capacity for growth. And actionable visibility protects that performance when the unexpected happens.
Our customers are doing extraordinarily important work. They're developing, distributing, and delivering medicine that improves and saves lives. Our job is to make that work easier.
John Doe
Jay McHarg is the CEO of AeroSafe Global, the world's leading provider of reusable temperature-assured packaging and Cold Chain as a Service. AeroSafe has delivered more than 40 billion therapies across 85+ countries with zero cold-chain excursions since 2014.
Related Article

From Distribution Excellence to Patient Excellence: How the Patient Is Driving Change and Driving the Industry to Take On a New Level of Innovation
One thing has become increasingly clear to me in 2026: some of the biggest problems in pharmaceutical logistics persist not because we haven …

The Last Mile Has Moved. It's Now a Patient Care Imperative.
One thing has become increasingly clear to me in 2026: some of the biggest problems in pharmaceutical logistics persist not because we haven …
.png)
The Next Chapter in Cold Chain Innovation Ends at the Front Door
One thing has become increasingly clear to me in 2026: some of the biggest problems in pharmaceutical logistics persist not because we haven …